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Abstract 
 
The incorporation of small bioactive peptide motifs within robust hydrogels constitutes a 
facile procedure to chemically functionalise cell and tissue scaffolds. In this study, a novel 
approach to utilise Fmoc-linked peptide amphiphiles comprising the bio-functional cell-
adhesion RGDS motif within biomimetic collagen gels was developed. The composite 
scaffolds thus created were shown to maintain the mechanical properties of the collagen gel 
while presenting additional improved bio-activity. In particular, these materials enhanced the 
adhesion and proliferation of viable human corneal stromal fibroblasts by 300% compared to 
non-functionalised gels. Furthermore, the incorporation of Fmoc-RGDS nanostructures 
within the collagen matrix significantly supressed gel shrinkage resulting from the contractile 
action of encapsulated fibroblasts once activated by serum proteins. These mechanical and 
biological properties demonstrate that the incorporation of peptide amphiphiles provides a 
suitable and easy method to circumvent biomaterial limitations, such as cell-derived 
shrinkage, for improved performance in tissue engineering and regenerative medicine 
applications. 
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Introduction 
 
The development of new natural and synthetic biomaterials with applications in tissue 
engineering and regenerative medicine is a major area of academic and commercial interest. 
Biomaterials are often designed to reproduce the in vivo environment of tissues, namely by 
providing a surface that emulates the native extracellular matrix (ECM), and to which cells 
can attach and interact.[1] Collagen gels are widely used as such biomaterials. These gels 
are comprised by a dense network of collagen fibrils, and form mechanically-stable scaffolds 
on which cells attach and grow.[2] Collagen gels have also been used extensively as 3D 
scaffolds, allowing cells to be cultured while encapsulated to generate functional tissue 
constructs. Furthermore, the mechanical properties of collagen gels can be easily and 
precisely modulated using several methodologies, namely through plastic compression and 
chemical cross-linking.[3, 4] Despite their many suitable qualities as a biomaterial, the 
limitations of collagen gels should be considered. For example in their native form collagen 
gels do not contain all the biological cues necessary for extensively recreating particular 
native ECM environments, and consequently impair cell function and/or viability.[5]  
Currently, the design of enhanced biomaterials is being supported by studies exploring the 
mechanisms controlling cell-ECM interactions. This knowledge has been successfully 
translated into improved surface chemistry functionalisation, i.e., the incorporation of 
biological motifs into biomaterials that serve as biological ligands, to better modulate cell 
behaviour.[6] In recent years, a considerable number of motifs have been developed and 
tested in both fundamental and clinical research settings.[7] These ligands have been used 
alone or in combination with other biomaterials to create artificial systems that better support 
growth and differentiation of cells and tissues in vitro.[8-10] Among these artificial systems, 
peptide amphiphiles (PAs) represent a class of simple and versatile molecules that allow the 
incorporation of a multitude of functional motifs in self-assembling structures.[11-13] 
Prominently, PAs comprising bioactive motifs linked to the aromatic N-(fluorenyl-9-
methoxycarbonyl) (Fmoc) group have previously been investigated for the development of 
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synthetic substrates with application in tissue engineering.[14, 15] Hydrogels containing the 
Fmoc group have been designed for rapid formulation via pH adjustments.[16, 17] 
Furthermore, previous work has proposed the use of Fmoc-PAs as two- or three-
dimensional scaffolds for cell culture.[14, 18, 19] Previous work has demonstrated the use of 
an Fmoc-RGD peptide amphiphile at 2 wt.% as a 2D scaffold for the support and growth of 
fibroblasts.[16] In this context, the use of an RGDS motif was expected to have enhanced 
bioactive properties.[20, 21] However, the mechanical and structural properties of Fmoc-
containing gels were found to be sub-optimal, forming scaffolds that often lack the durability 
required to adequately support cells for long in vitro culture periods. Recently, it was 
reported that hydrogels produced from 2 wt.% Fmoc-RGDS showed the onset of syneresis 
when subjected to shearing at low strains.[22] Furthermore, these hydrogels were unable to 
withstand contact with cell culture media or temperatures at 37 °C without dissolving or 
becoming compliant.  
As such, we propose that self-assembling Fmoc-PAs can be used in combination with 
biologically-relevant scaffolds such as collagen gels to produce novel functional biomaterials 
with improved mechanical stability and increased/tuneable bioactivity.   
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Materials and Methods 
Preparation of PA-functionalised collagen gels 
The bio-functional peptide amphiphile (fPA) comprised of the Fmoc molecule linked to the 
Arg-Gly-Asp-Ser (RGDS) cell adhesion peptide was supplied by CS Bio (Menlo Park, USA) 
and characterised elsewhere.[22] The fPA was incorporated into collagen gels to increase 
the biomaterials functionality. To create these functionalised collagen gels, the lyophilised 
fPA was weighed, solubilised in ultrapure water at 1 wt. % (1.52×10-2 M), and added to ice-
cold rat tail collagen type-I (2 g.L-1 in 0.6% acetic acid; First Link Ltd, UK) previously mixed 
with 10× Modified Essential Medium (Life Technologies, USA) and neutralised with 1 M 
NaOH at a 1:7:1:1 volume ratio, respectively. Non-functionalised (control) collagen gels were 
prepared by replacing the fPA solution with same volume of ultrapure water. The fPA-
supplemented, and control collagen solutions were then cast into either 12 or 24 mm Ø 
Transwell plate inserts (Corning, USA), using 1 or 4 mL aliquots for the 1.12 or 4.67 
cm2 surface areas, respectively, and allowed to polymerise at 37 °C and 5 % CO2 for 30 
minutes. The resulting gels were either maintained uncompressed or plastically-compressed 
as previously described,[23] using a 134 g load for 5 minutes at room temperature.[24] 
Fibronectin coating was performed by incubating non-functionalised compressed collagen 
gels with human fibronectin (R&D systems, USA) in solution (5 µg of protein.cm2 of gel 
surface) overnight. Gels with encapsulated cells were produced as described above. In this 
instance, 1 wt. % (1.52×10-2 M) fPA was solubilised in DMEM:F12 (Live Technologies, USA), 
and the resulting fPA solution was used to re-suspend cells. 
 
Rheology of PA-functionalised collagen gels 
The rheological properties of fPA-functionalised compressed and uncompressed collagen 
gels were investigated using a controlled stress AR-2000 rheometer (TA Instruments, USA) 
with a plate-plate geometry (20 mm Ø). Preliminary stress sweeps were carried out at a fixed 
frequency of 2π radians over a stress range of 1×10-1-102 Pa at 37 °C for all samples. 
Frequency sweep measurements were then performed at an angular frequency range of 
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×10-1-102 rad.s-1 under a controlled stress corresponding to the linear viscoelastic region of 
each sample (0.7 and 1 Pa for uncompressed and compressed gels, respectively). 
 
Expansion of cells on fPA-functionalised collagen gels in 2D culture 
Human stromal corneal fibroblasts (hCSFs) from human corneal rings (kindly provided by 
Mr. Martin Leyland, Royal Berkshire Hospital) were isolated as previously described,[20] and 
seeded onto fPA-functionalised (+fPA), fibronectin-coated (+Fn), or non-functionalised 
(control) compressed collagen gels covering the entire surface of 24 mm Ø Transwell 
inserts. Briefly, trypsinised hCSFs were re-suspended in DMEM:F12 medium supplemented 
with 10 % foetal bovine serum (FBS; Biosera, France), seeded onto the gels at a density of 
1.5×104 cells.cm2 of gel surface, and maintained at 37 °C for 5 days. Culture media was 
replaced daily. 
 
Live/Dead double-staining of human corneal stromal fibroblasts (hCSFs) 
The growth of hCSFs on fPA-functionalised compressed collagen gels was examined using 
the live/dead double-staining kit (Calbiochem, UK) following 5 days in culture. Briefly, the 
collagen gels were transferred onto microscope slides and incubated in the dark for 15 min 
at 37 °C with staining buffer supplemented with 1:1000 cyto-dye and propidium iodide 
solutions. Slides were then examined using an Axio Imager upright fluorescence microscope 
(Zeiss, Germany) coupled with a digital video camera (CoolSnap, RS Photometrics, USA) to 
observe the presence of live (green-stained) and dead (red-stained) cells. Fluorescence 
images (≤ 12 for each gel condition) were analysed using the ImageJ (v1.46) software to 
quantify the number of live and dead cells and subsequently calculate cell viability.  
 
Encapsulation of hCSFs in fPA-functionalised collagen gels in 3D culture 
Cells used for encapsulation were re-suspended in DMEM:F12 with or without 1 wt % fPA 
(+fPA or control gels, respectively) at 2×105 cells per mL of medium prior to collagen gel 
polymerization. Uncompressed gels were then transferred to 6-well polystyrene culture 
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plates and maintained for seven days in DMEM:F12 without serum (SFM), with 5% FBS 
(+FBS), or supplemented with both serum and 5×105 M of fPA or cyclic-RGD peptide 
(cRGD; CS Bio). Total number of cells encapsulated within each gel condition was 
determined at day 7 using the Alamar Blue assay as previously described.[20] Each 
condition was tested in triplicate, in three independent experiments. 
 
Contraction of fPA-functionalised collagen gels 
Uncompressed collagen gels containing encapsulated cells were imaged using a Nikon 
digital camera immediately after polymerisation and at day seven. Images were analysed 
using ImageJ (v.1.46) to determine the area of the gels, and contraction at day 7 calculated 
as percentage of initial gel area, and normalized by cell number. Each condition was tested 
in triplicate, in three independent experiments. 
 
Immunofluorescence analysis 
Encapsulated cells were fixed in 4% paraformaldehyde for 20 min, washed three times with 
PBS for 15 min, blocked for 1 h in PBS supplemented with 2% goat serum and 2% BSA. The 
3D constructs were then incubated with anti-α-smooth muscle actin antibody (MAB1420, 
R&D systems) in blocking solution (1:1000) for 2 h, washed three times with PBS for 15 min, 
and incubated with 1:1000 goat anti-mouse IgG1 conjugated to Alexa 488 (A11001, 
Invitrogen) for an additional hour. Samples were mounted in VectaShield mounting media 
containing 4',6-diamidino-2-phenylindole (DAPI) (Vector Labs, UK) to label cell nuclei and 
imaged using a AxioImager fluorescence microscope (Zeiss) coupled with a digital video 
camera (CoolSnap, RS Photometrics, USA). 
 
Statistical analysis 
Data (average ± S.D.) was evaluated using two-way ANOVA followed by Tukey’s post-hoc 
tests. Significant differences were considered for p < 0.05. 
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Results and Discussion 
Mechanical characterisation of fPA-functionalised collagen gels 
In this study we used the self-assembling Fmoc-Arg-Gly-Asp-Ser peptide amphiphile 
(henceforth designated fPA) in combination with compressed and uncompressed collagen 
type-I gels to create functionalised scaffolds presenting a more attractive environment for 
cell attachment and growth. The viscoelastic properties of fPA-functionalised gels were 
tested by rheology, as shown in Fig.1. Compressed fPA-collagen gels were shown to be 
flexible, with the elastic modulus (G’) largely independent of shear frequency (Fig.1). 
Notably, the elastic modulus values for compressed fPA-collagen gels reported here (Table 
1) were comparable to the values obtained previously for non-functionalised compressed 
collagen gels (~2900 Pa).[24] In contrast, uncompressed fPA-collagen gels showed 
increased elastic and viscous moduli (G’’) at higher shear frequencies (Fig. 1), an effect 
referred to as strain-stiffening. This effect is commonly observed in semi-flexible biological 
polymers, and has been associated with the capacity of tissues to prevent large 
deformations and consequent loss of integrity.[25] Furthermore, the elastic modulus of 
uncompressed fPA-collagen gels (Table 1) was higher than that from non-functionalised gels 
(1-4 Pa) at an equivalent angular frequency range,[24] suggesting that the self-assembled 
nanostructures of fPA were integrated within the matrix formed by the collagen type-I fibrils. 
Taken together, these results showed that both compressed and uncompressed fPA-
collagen gels were stable, with mechanical properties similar to corresponding non-
functionalised gels. This suggests that collagen gels can tolerate the incorporation of fPA 
without substantially changing their mechanical structure. Moreover, the fPA-functionalised 
gels can be compared with the well-established non-functionalised collagen gels in a wide 
range of applications.  
 
Expansion and viability of cells grown on fPA-functionalised collagen gels 
In order to test the capacity of fPA-collagen scaffolds to support cell adhesion and 
proliferation, human corneal stromal fibroblasts (hCSFs) were seeded onto functionalised 
9 
 
(+fPA) and non-functionalised (control) gels after plastic compression. In addition, non-
functionalised compressed collagen gels were coated with fibronectin (+Fn) and used as 
positive controls for bioactivity. Fibronectin is a natural protein that contains the cell-
adhesion motif Arg-Gly-Asp (RGD),[26] a peptide sequence previously shown to promote 
cell adhesion, proliferation, and differentiation through its interaction with several classes of 
integrins.[27] Cells cultured on these gels for five days were then stained with calcein and 
propidium iodide and then imaged by fluorescence microscopy (Fig. 2). As a cell-permeable 
dye, calcein is able to penetrate live cells, which then can be identified by emission of green 
fluorescence. In contrast, the red fluorescent propidium iodide dye is cell-impermeable, and 
is only incorporated by cells with porous membranes (i.e., dead cells). The analysis of 
images from the live/dead cell assay showed that +fPA gels significantly promoted the 
survival of hCSFs when compared to non-functionalised gels (Fig. 2). This effect 
corresponded to a 1.3-fold increase in the percentage of viable cells on +fPA (82 ± 7%) 
compared to control gels, where viability was only 61 ± 9% (Fig. 2b). In addition, the total 
number of cells growing on +fPA was significantly higher and corresponded to a 3-fold 
increase over control gels (Fig. 3). This indicated that the fPA nanostructures incorporated 
within the collagen gels were bio-functionally active, and that their RGDS motifs were 
capable of interacting with cells to promote attachment and proliferation. This interpretation 
was supported by the differences in cell morphology observed between +fPA and control 
gels. Cells grown on functionalised gels appeared more elongated and spindle-shaped (Fig 
2a, arrows) compared to hCSFs on non-functionalised collagen gels, which appeared more 
rounded. The characteristic anchorage-dependent, elongated phenotype is controlled in vivo 
by interaction between cell adhesion molecules expressed at the cell membrane (e.g., 
integrins) and their corresponding binding partners present in the surrounding ECM. 
Previous studies have shown that, in vitro, the stiffness of compressed collagen substrates 
affects cell-substrate adhesion.[24, 28] However, and as discussed above, the mechanical 
properties of compressed collagen gels were unchanged by fPA functionalisation, indicating 
that enhanced cell adhesion and proliferation on +fPA gels was due to incorporation of the 
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bio-functional RGDS motif carried by the fPA nanostructures, followed by downstream 
activation of integrin-mediated signalling pathways.[29] This conclusion was reinforced by 
the prevalence of spindle-shaped cells in +Fn gels (Fig. 2a). The fibronectin-coated gels also 
enhanced hCSF proliferation significantly compared to the controls, although at lower levels 
than on +fPA (Fig. 3). However, this coating did not affect cell viability when compared to 
control gels (Fig. 2b). These discrepancies may be due to the lower density of functional 
motifs in +Fn compared to fPA-functionalised gels.  
 
 
Contraction of fPA-functionalised collagen gels containing encapsulated cells 
Collagen gels used as scaffolds for cell encapsulation or as vehicles for tissue grafting are 
usually prone to remodelling resulting from intrinsic or extrinsic activity of cells. Most 
commonly, collagen gels change their shape irreversibly in response to the contractile action 
of encapsulated cells.[30] Consequently, transplanted collagen gels may contract, leading to 
delayed graft integration,[31] tissue deformation,[32] and scar contracture.[33, 34] In order to 
determine the ability of fPA functionalisation in circumventing this effect, we tested changes 
in shape from +fPA and control collagen gels containing encapsulated hCSFs. These cells 
were employed for this assay because they can differentiate from a non-contractile to a 
highly-contractile, alpha-smooth muscle actin (αSMA)-positive phenotype simply by being 
incubated in FBS-supplemented culture medium (+FBS). Conversely, incubation of hCSFs in 
serum-free media (SFM) maintains cells in  a non-contractile, quiescent phenotype, where 
αSMA-positive stress fibres are absent.[35] Uncompressed gels were used for this particular 
experiment to facilitate contraction whilst maintaining cell attachment and growth. Moreover, 
the uncompressed gels showed to be semi-flexible (Fig. 1), with mechanical properties  
comparable to other natural cellular and ECM polymers occurring in vivo (e.g., F-actin,[36] 
vimentin,[37] and fibrin[38]).  
After seven days in SFM culture, contraction of collagen gel was minimal, and independent 
of fPA functionalisation (Fig. 4a). In contrast, reduction of gel size was maximised in serum-
containing conditions (+FBS) (Fig. 4). Nevertheless, the contraction of +fPA gels (to 28 ± 2% 
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of the initial gel area) was significantly inhibited when compared to non-functionalised gels, 
which were reduced to just 6 ± 2% of their initial size (Fig. 4b). Collagen gel contraction was 
further inhibited with the supplementation of +FBS culture media with soluble fPA (+sPA) or 
cyclic-RGD peptide (+cRGD) to block integrins from hCSFs. Both soluble factors significantly 
impaired contraction of fPA-functionalised and control gels, although this inhibition was much 
more evident for +fPA constructs (Fig. 4). These results were in line with previous studies 
where the inhibition of integrins reduced the contractile force exerted by cardiac 
myocytes,[39] chinese hamster ovary cells,[40] mesangial cells,[41] and human dermal 
fibroblasts.[42] 
The levels of gel contraction were well correlated with the phenotype of the encapsulated 
cells. When observed by phase-contrast microscopy at day 7, encapsulated hCSFs cultured 
in SFM showed a dendritic morphology characteristic of non-contractile, quiescent cells (Fig. 
5a, arrows), whereas cells in +FBS were extended and flattened (Fig. 5a), assuming the 
shape of myofibroblasts. Differences between non-contractile and contractile myofibroblastic 
phenotypes were confirmed by immunofluorescence microscopy (Fig. 5b), where SFM cells 
were αSMA-negative and +FBS cells exhibited defined αSMA-positive stress fibres. Gels 
maintained in +FBS supplemented with either +sPA or +cRGD had αSMA-positive cells (Fig. 
5b). However, fPA-collagen gels maintained in these conditions still exhibited dendritic, non-
contractile cells (Fig. 5a, arrows), whereas no dendritic hCSFs remained in control gels. 
Taken together, these results indicated that collagen gel contraction was induced by the 
contractile activity of myofibroblastic hCSFs, and that fPA prevented, in part, the formation of 
spindle shaped cells and the action of such contractile cells on the collagen gel matrix. 
Moreover, integrin blocking through the use of soluble fPA further prevented the contractile 
activity of cells to be exerted on the gels without affecting the overall cell phenotype.  
These effects can be explained by the presence of a sub-matrix of fPA nanostructures within 
the collagen gel matrix performing as a scaffold-within-a-scaffold, and to which hCSFs would 
preferentially adhere. When activated by serum, attached cells would exert their contractile 
action on this sub-matrix, thus reducing the overall contraction of the collagen gel matrix. 
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The use of integrin blockers would dissociate hCSFs from the surrounding matrices, and 
further prevent gel shrinkage. 
 
Conclusion 
  
This work demonstrates an alternative use of PAs comprising the Fmoc group coupled with 
bioactive motifs. When combined with collagen, the fPA provided functional cues 
incorporated within a polymerised scaffold, and produced a novel composite biomaterial that 
enhanced cell attachment, proliferation, and viability through specific cell-substrate 
interactions. This may be a more practical alternative application of Fmoc-PAs due to their 
hydrolytic capabilities under basic pH conditions. Furthermore, both compressed and 
uncompressed collagen gels have tissue-like qualities that make them highly amenable for 
use in transplantation. The use of fPA was shown to prevent the contraction resulting from 
intrinsic cellular activity in functionalised collagen scaffolds. This work highlights for the first 
time the enhanced bioactivity of amino acid sequences in functionalised collagen gels for 
use as biomaterials for engineering artificial tissue structures. 
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Table 1: Elastic modulus (G′) of compressed and uncompressed fPA-functionalised collagen 
gels determined by shear rheology and using an angular frequency of 1 rad.s-1. 
  fPA-collagen gels G′ Modulus (Pa) 
  Compressed  2900  
  Uncompressed  40  
 
 
 
Table 1 (alternative): Elastic modulus (G′) of compressed and uncompressed fPA-
functionalised collagen gels determined by shear rheology and using an angular frequency 
of 1 and 100 rad.s-1. 
 
  fPA-collagen gels Angular frequency (rad.s-1) G′ Modulus (Pa) 
  Compressed  
1  2900  
100  4640  
  Uncompressed  
1  40 
 
100  1660  
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Figure legends 
Figure 1: Rheology of fPA-functionalised collagen gels using frequency sweep 
measurements. Plastic compression altered the viscoelastic properties of fPA-
functionalised gels, with compressed gels (black) having higher elastic (G’; circles) and 
viscous moduli (G′′; squares) compared to those left uncompressed (white symbols). 
 
Figure 2: Viability of human corneal stromal fibroblasts (hCSFs) cultured on 
compressed collagen gels. Cells grown for five days on uncoated (control), fPA-
functionalised (+fPA), or fibronectin-coated collagen gels (+Fn) were a) imaged by 
fluorescence microscopy after calcein (green)/ propidium iodide (PI, red) double staining. 
The arrows indicate spindle-shaped cells. Scale bars, 200 µm. b) The percentage of live, 
calcein-positive/ PI-negative cells was quantified for all three conditions, with differences in 
viability evaluated by two-way ANOVA followed by Tukey’s post hoc tests (average ± S.D. 
from three independent experiments, n = 3; * corresponded to p < 0.05). 
 
Figure 3: Effect of fPA in the proliferation of human corneal stromal fibroblasts 
(hCSFs) cultured on compressed collagen gels. The total number of live cells grown for 
five days on uncoated (control), fPA-functionalised (+fPA), or fibronectin-coated collagen 
gels (+Fn) was quantified and expressed as a percentage of control (uncoated compressed 
collagen gels). Differences in cell numbers were evaluated by two-way ANOVA followed by 
Tukey’s post hoc tests (average ± S.D. from three independent experiments, n = 3; * and ** 
corresponded to p < 0.05 and 0.01, respectively). 
 
Figure 4: Effect of fPA functionalisation in collagen gel contraction. Human corneal 
stromal fibroblasts (hCSFs) were encapsulated within PA-functionalised (+fPA) or non-
functionalised collagen gels (control) and cultured for seven days with serum-free (SFM) or 
serum-containing medium (+FBS), to avoid or elicit gel contraction, respectively. Inhibition of 
gel contraction through blocking of hCSFs’ integrins was also performed by adding 50 µM of 
19 
 
soluble PA or cyclic-RGD peptide to serum-containing medium (+sPA or +cRGD, 
respectively). a) Representative photographs of collagen gels at day 7 were superimposed 
over images taken from the same gels immediately after formation at day 0 (traced line). 
Scale bars, 4 mm. b) Contraction at day 7 was evaluated relatively to each gel’s initial area 
at day 0, and differences in size within differently-treated control (i) or +PA gels (ii), and 
between control and +PA gels (iii) were evaluated by two-way ANOVA followed by Tukey’s 
post hoc tests (average area ± S.D. from three independent experiments, n = 3; *, **, and *** 
corresponded to p < 0.05, 0.01, and 0.001, respectively). 
 
Figure 5: Effect of fPA functionalisation in the activation of human corneal stromal 
fibroblasts (hCSFs) cultured within collagen gels. The hCSFs were encapsulated within 
PA-functionalised (+fPA) or non-functionalised collagen gels (control) and cultured for seven 
days with serum-free (SFM) or serum-containing medium (+FBS), to avoid or elicit cell 
activation, respectively. The effect of integrin blocking on hCSF activation was also tested by 
adding 50 µM of soluble PA or cyclic-RGD peptide to serum-containing medium (+sPA or 
+cRGD, respectively). a) Representative phase-contrast micrographs of gels at day 7, with 
dendritic-shaped hCSFs (arrows). Scale bars, 50 µm. b) Immunofluorescence microscopy 
analysis of collagen gels stained with anti-αSMA antibody (green) and DAPI (cyan). Scale 
bars, 20 µm. 
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